Xenon Pharmaceuticals Inc (NAS:XENE)
$ 43.33 1.62 (3.88%) Market Cap: 3.28 Bil Enterprise Value: 2.45 Bil PE Ratio: 0 PB Ratio: 3.88 GF Score: 41/100

Xenon Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 01, 2022 / 06:30PM GMT
Release Date Price: $26.68 (+1.25%)
Simon N. Pimstone
Xenon Pharmaceuticals Inc. - Chairman of the Board

Welcome to Xenon's 2022 Annual General Meeting. My name is Simon Pimstone and it's my sincere pleasure to chair this AGM in the capacity of Xenon's Executive Chair of the Board. Attending the meeting today with me is Ian Mortimer, the Corporation's President and Chief Executive Officer and Director.

Certain of our other directors, officers and employees are also attending the meeting. I'd like to thank and acknowledge their contributions to Xenon over the past year. I'd also like to take this opportunity to recognize Dr. Michael Hayden, who is not standing for reelection at this meeting. Michael has been instrumental to Xenon's success as a Co-Founder, Chief Scientific Officer for many years and long-standing member of our Board. On behalf of the entire Xenon family, I'd like to thank Michael for his over 25 years of loyalty and dedication to the corporation. We owe a great debt of gratitude to Michael and I, too, am personally grateful for his mentorship, his support and great friendship over the many years.

This

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot